Berzosertib Human Mass Balance Study (DDRiver Solid Tumors 208)
Clinical trial NCT05246111 · COMPLETED
Trial details
- NCT number
- NCT05246111
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2023-06-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.